> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Revokes 5 Covid Test EUAs
- URL: https://www.fdaweb.com/fda-revokes-5-covid-test-euas-2/
- Published: 2022-04-18T12:00:00.000Z
- Updated: 2026-09-14T17:41:06.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151616

*Federal Register* notice: FDA is revoking the emergency use authorizations issued to BillionToOne, Inc. for the qSanger-Covid–19 Assay, RTA Laboratories Biological Products Pharmaceutical and Machinery Industry for the Diagnovital SARS–CoV–2 Real-Time PCR Kit, DiaSorin Inc. for the DiaSorin Liaison SARS–CoV–2 IgM Assay, and Centogene US, LLC for both the Cento Fast-SARS–CoV–2 RT–PCR Assay and Cento Sure SARS–CoV–2 RT–PCR Assay. The companies have notified the agency that the tests are no longer being marketed. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-04-18/pdf/2022-08230.pdf?ref=fdaweb.com).